Avid Bioservices Inc is a company that values innovation, integrity, and reliability. With a corporate philosophy focused on delivering high-quality biologics manufacturing, Avid Bioservices Inc aims to provide efficient and dependable solutions to the biotechnology and pharmaceutical industries. The company prides itself on its commitment to meeting client needs, exceeding expectations, and maintaining strong relationships with its partners. Avid Bioservices Inc's dedication to cutting-edge technologies and compliance with regulatory standards enables them to consistently deliver exceptional, cost-effective services. By upholding these values and corporate philosophy, Avid Bioservices Inc has established itself as a trusted and leading provider in the biopharmaceutical contract development and manufacturing industry.

Avid Bioservices Inc is primarily present in the United States.

Avid Bioservices Inc has achieved several significant milestones. The company successfully completed the expansion of its Myford manufacturing facility, which increased its production capacity to meet growing demand. Additionally, Avid Bioservices achieved key regulatory milestones by obtaining FDA approval for multiple biologics produced at its facilities. The company also secured several strategic partnerships and collaborations with renowned pharmaceutical companies, further establishing its position in the market. Furthermore, Avid Bioservices successfully delivered consistent and high-quality manufacturing services, leading to increased customer satisfaction and repeat business. These achievements reflect the company's dedication to innovation, quality, and providing exceptional biomanufacturing solutions.

Avid Bioservices Inc is a reputable biotechnology company with a rich history and background. Established in 1981, the company has become a leading provider of biomanufacturing services, specializing in the development and production of monoclonal antibodies and recombinant proteins. Avid Bioservices Inc is committed to delivering high-quality, innovative solutions to the biotech industry, serving both large pharmaceutical companies and small biotech firms. With state-of-the-art facilities and a team of experienced scientists, the company has earned a commendable reputation for its expertise in cell culture, process development, and manufacturing. Avid Bioservices Inc consistently strives towards advancing healthcare through its cutting-edge biomanufacturing capabilities.

The main competitors of Avid Bioservices Inc in the market are Cytovance Biologics, Inc., Lonza Group Ltd., AbbVie Inc., and Catalent, Inc.

Avid Bioservices Inc is primarily active in the biotechnology and pharmaceutical industries.

Avid Bioservices Inc is a leading contract development and manufacturing organization (CDMO) that provides comprehensive services for the biotechnology and pharmaceutical industries. The company's business model revolves around offering a wide range of solutions for the development, manufacturing, and commercialization of biologic products. Avid Bioservices specializes in the production of monoclonal antibodies, recombinant proteins, and other biologics. Their state-of-the-art facilities, experienced team, and quality-driven approach enable them to deliver efficient and cost-effective solutions to their clients. With a focus on meeting regulatory requirements and maintaining high standards, Avid Bioservices Inc continues to play a crucial role in supporting biopharmaceutical companies in advancing their therapeutic innovations.

Avid Bioservices의 P/E 비율은 -40.82입니다.

Avid Bioservices의 P/S 비율은 4.75입니다.

Avid Bioservices에 대한 AlleAktien 품질 점수는 4/10입니다.

예상되는 Avid Bioservices 매출은 166.34 백만 USD입니다.

예상되는 Avid Bioservices 이익은 -19.34 백만 USD입니다.

Avid Bioservices Inc is a biopharmaceutical company specializing in the development and manufacturing of biopharmaceuticals. The company offers integrated development services and manufacturing services to various customers, including pharmaceutical and biotech companies. The company provides a wide range of services, including manufacturing of clinical batches, scale-up processes, and process optimization. They have a fully integrated GMP production facility in California, USA, and produce both recombinant proteins and monoclonal antibodies. One of the main divisions of Avid Bioservices is the development of cell lines for biopharmaceutical production. They use their expertise in molecular biology to select and develop recombinant cell lines suitable for biopharmaceutical production. They work closely with customers to develop customized cell lines tailored to the requirements of biopharmaceuticals. Another division of Avid Bioservices is the manufacturing of clinical batches of biopharmaceuticals. They have the expertise and capacity to scale production processes and conduct commercial production of biopharmaceuticals. They are capable of producing batches in various sizes, including batches for Phase I, Phase II, and Phase III clinical studies. The company also offers process optimization services to improve the production of biopharmaceuticals. They have extensive experience in transferring production processes from the laboratory to the production scale. They utilize their expertise in process optimization to improve production efficiency and quality, and reduce production costs. The products of Avid Bioservices include a wide range of recombinant proteins and monoclonal antibodies, such as enzymes, hormones, growth factors, antibodies, and other biopharmaceuticals. They work closely with customers to develop customized biopharmaceuticals that meet the specific requirements of diseases. In collaboration with its customers, Avid Bioservices aims to accelerate the clinical development of biopharmaceuticals and expand the available selection of biopharmaceuticals. The company strives to make the production of biopharmaceuticals more efficient, high-quality, and cost-effective. In summary, Avid Bioservices is a biopharmaceutical company specializing in integrated development services and manufacturing services. They offer a wide range of products and services, including the development of cell lines, manufacturing of clinical batches, process optimization, and production of recombinant proteins and monoclonal antibodies. Avid Bioservices aims to accelerate the development of biopharmaceuticals and improve the production of biopharmaceuticals in terms of efficiency, quality, and cost-effectiveness.

Avid Bioservices은(는) 연간 번의 배당을 통해 0 USD의 배당금을 지급합니다.

Avid Bioservices의 현재 배당금은 계산할 수 없거나, 회사가 배당금을 지급하지 않습니다.

Avid Bioservices의 ISIN은 US05368M1062입니다.

Avid Bioservices의 WKN은 A2JBKV입니다.

Avid Bioservices의 티커는 CDMO입니다.

지난 12개월 동안 Avid Bioservices은(는) 의 배당금을 지급했습니다. 이는 약 의 배당 수익률에 해당합니다. 향후 12개월 동안 Avid Bioservices은(는) 0 USD의 배당금을 지급할 것으로 예상됩니다.

Avid Bioservices의 현재 배당 수익률은 입니다.

Avid Bioservices은 분기별로 배당금을 지급합니다. 이는 월에 배당됩니다.

Avid Bioservices은(는) 지난 0년 동안 매년 배당금을 지급했습니다.

향후 12개월 동안 0 USD의 배당금이 예상됩니다. 이는 배당수익률 0 %에 해당합니다.

Avid Bioservices은 '건강' 섹터에 속합니다.

Avid Bioservices의 마지막 배당금을 0 USD만큼 받기 위해선 의 Ex-Tag 전에 주식을 보유하고 있어야 했습니다.

마지막 배당금 지급일은 입니다.

2024년에 Avid Bioservices는 0 USD를 배당금으로 지급했습니다.

Avid Bioservices의 배당금은 USD에 지급됩니다.